Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KalVista Pharmaceuticals (KALV) Current Assets: 2014-2024

Historic Current Assets for KalVista Pharmaceuticals (KALV) over the last 8 years, with Apr 2024 value amounting to $225.7 million.

  • KalVista Pharmaceuticals' Current Assets was N/A to $286.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $286.0 million, marking a year-over-year change of. This contributed to the annual value of $225.7 million for FY2024, which is N/A change from last year.
  • Latest data reveals that KalVista Pharmaceuticals reported Current Assets of $225.7 million as of FY2024, which was up 154.45% from $88.7 million recorded in FY2020.
  • In the past 5 years, KalVista Pharmaceuticals' Current Assets registered a high of $225.7 million during FY2024, and its lowest value of $88.7 million during FY2020.
  • For the 1-year period, KalVista Pharmaceuticals' Current Assets averaged around $225.7 million, with its median value being $225.7 million (2024).
  • Data for KalVista Pharmaceuticals' Current Assets shows a maximum YoY fell of 23.24% (in 2020) over the last 5 years.
  • KalVista Pharmaceuticals' Current Assets (Yearly) stood at $88.7 million in 2020, then followed by $225.7 million in 2024.